NASDAQ:PEP

PepsiCo (PEP)

141.52
-2.67 (1.85%)
as of Jun 1, 2026, 8:00:00 pm Market Open.
234 watching
0
Investor Insights
star iconJun 1, 2026, 12:00 am

This summary was created by AI, based on 8 opinions in the last 12 months.

PepsiCo (PEP) is facing challenges primarily due to the rise of GLP-1 weight-loss drugs, which are affecting consumer cravings and leading to health-conscious eating habits among younger generations. Despite this, the company has a strong Frito-Lay snack franchise and pays a solid 4% dividend, positioning it as a reliable investment. Analysts note that Elliott Management's recent stake purchase indicates confidence in the company's future. However, comparisons with Coca-Cola reveal a performance gap, with PEP down 7% while KO has gained 7% this year. The overall sentiment is mixed, reflecting both cautious optimism about its strong brand and concerns about the changing consumer landscape.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
KO
BUY

They report Thursday. He's impressed by how they've dealt with the rise of GLP-1 drugs and healthy diets among the young. The CEO listens to customers.

COMMENT

 It reports Tuesday. He worries about it because of its snack division which has been struggling against the weight-loss drugs. Shares moved up today.

DON'T BUY

They report Thursday. They've had it tough lately, but have a strong Frito-Lay snack franchise. Also pays a solid 4% dividend. However, the younger generation is watching their health, and people are taking weight-loss drugs, GLP-1 which diminishes cravings. PEP is -7% this year vs. Coke +7%.

BUY

Pays a safe 4% yield. Shares are bottoming now. Own, don't trade.

BUY

Remains a premium growth company. Elliott Management just took a big stake, and he likes this activist firm. Shares are 7 points below before Elliott stepped in--a bargain. Also, this yields almost 4% because shares have fallen so much.

DON'T BUY

It reports Thursday. It trades at a low 17x PE. Headwinds: GLP-1 drugs, RFJ Jr. who despises junk food though embraces junk science, and the desire to stay healthy. It's a tough industry.

DON'T BUY

He sold in 2024 when the valuation started looking a bit full. When pandemic inflation hit, "elasticity" was low so that consumers kept buying despite higher prices. Cumulative effect of inflation caught up to them. Not tempted, given slowing macro economy and inflation genie not fully back in the bottle.

HOLD

Operates in a cola duopoly with KO, good job creating shareholder value. He likes market leaders like these that have little to no direct competition, so this name fits that bill. That being said, it's a lot harder these days with consumer brands to establish a brand and build a moat. Today he could launch a cola company online, using Instagram and FB, with very little cost and effort, and with luck it could even go viral. Brands will have a tough time. 

Very strong, well-established brand. PEP got into snacks, which are up against healthier lifestyles. He owns FEVR, take a look at that one.

DON'T BUY

An amazing company and major soft drinks maker. Shares are far from its last highs, so low that the dividend now pays 4.42%. Suppose RFK Jr. goes after companies that produce caloric snacks? Share are very undervalued, but who knows when shares will stop going down?

BUY

Yields 4%, well-run and can start a position at 16x PE. They will right the ship. 

COMMENT

Was just downgraded. The consumer is fed up with shrinking product, like potato chips per bag. Consumer products must take the hit and lower prices like this, which will shrink margins. But it's worth it as opposed to this shrinkage. 

BUY

Rallied 2.95% in today's sell-off as people sough safety in stocks that do well in a recession. Pays a 3% dividend.

DON'T BUY

Historic growth story of Pepsi was the Frito-Lay franchise. Not the growth company it was. Still trades at a reasonably high multiple for its growth rate. International sources of revenue, so the strong USD is a major headwind.

Companies in the snack space have traded off on the fears of GLP-1. Volumes are starting to drop. Growth metrics just don't support the valuations.

DON'T BUY

It reports Tuesday. The weight-loss drugs make it hard for PEP to thrive. It pays a 3.6% dividend, though.

DON'T BUY

GLP weight-loss drugs have hurt, and in some countries like India PEP has faced headwinds over their use of water, which is scarce is those places. 

Showing 1 to 15 of 195 entries

PepsiCo (PEP) Frequently Asked Questions

What is PepsiCo stock symbol?

PepsiCo is a American stock, trading under the symbol PEP (previously PEP-Q on Stockchase) on the NASDAQ (PEP). It is usually referred to as NASDAQ:PEP or PEP

Is PepsiCo a buy or a sell?

In the last year, 7 stock analysts published opinions about PEP (previously PEP-Q on Stockchase). 3 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is DON'T BUY. Read the latest stock experts' ratings for PepsiCo.

Is PepsiCo a good investment or a top pick?

PepsiCo was recommended as a Top Pick by John O'Connell, CFA on 2025-01-13. Read the latest stock experts ratings for PepsiCo.

Why is PepsiCo stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is PepsiCo worth watching?

7 stock analysts on Stockchase covered PepsiCo in the last year. It is a trending stock that is worth watching.

What is PepsiCo stock price?

On 2026-06-01, PepsiCo (PEP) stock closed at a price of $141.52.